About
- Home
- About
Dream Genomics
Dream Genomics is a visionary biotech firm at the forefront of combating Chronic Wasting Disease (CWD) in cervids through advanced genomic discovery. Founded by a team of experts in diagnostics and genomic research, our mission is to discover, develop, and produce a blood test for CWD in live cervids. Further, our goal is to safeguard wildlife populations, support the hunting and farming industries, and protect public health through our groundbreaking work.
Gary M. Pusateri, M.D., CEO and Founder
An avid outdoorsman with 14 years of experience in the genomic space. He’s recently retired from clinical medicine with more than 35 years of experience in family practice and emergency medicine. He has been an admired leader, mentor and medical director throughout his years of practice.
“My passion for nature, wildlife, and the outdoors started at an extremely young age. It is what led me to the idea to create Dream Genomics Inc. The opportunity to combine that passion with my partners expertise and proprietary methods for diagnosis, along with the knowledge we have gained through Paradise Genomics Inc. is ideal.
We are personally, financially, and technically committed to making our first diagnostic a blood test in live Deer for Chronic Wasting Disease.”
Michael T. Falduto, PH.D., CHIEF TECHNOLOGY OFFICER AND FOUNDER
Co-founded GenUs BioSystems, Inc., and Paradise Genomics, Inc.,
Former senior scientist at Abbott Laboratories in the Diagnostic & Pharmaceutical Products Divisions
Dr. Falduto has nearly 4 decades of experience in measuring and analyzing gene expression and discovering genomic signatures.
Scott R. Magnuson, Ph.D., CHIEF SCIENTIFIC OFFICER AND FOUNDER
Co-founded GenUs BioSystems, Inc. and Paradise Genomics, Inc. Previously at Motorola Life Sciences, Dr. Magnuson was instrumental in the development of the CodeLink™ microarray products where he was Head of Gene Expression, Genomics, and Bioinformatics.
He was formerly a senior scientist at Abbott Laboratories, where he spent 10 years investigating cancer, cardiovascular disease and genomics for drug discovery.